Viewing Study NCT01020305


Ignite Creation Date: 2025-12-25 @ 3:13 AM
Ignite Modification Date: 2026-07-01 @ 12:04 AM
Study NCT ID: NCT01020305
Status: TERMINATED
Last Update Posted: 2014-10-13
First Post: 2009-10-30
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer
Sponsor:
Organization: